Introduction: This study evaluated the effects of the dietary supplement omega 3 polyunsaturated fatty acids (u-3 PUFAs) on pulp exposure-induced apical periodontitis (AP) in rats. Methods: Twenty-eight male rats were divided into groups: control untreated rats (C), control rats treated with u-3 PUFAs alone (C-O), rats with pulp exposure-induced AP, and rats with pulp exposure-induced AP treated with u-3 PUFAs (AP-O). The u-3 PUFAs were administered orally, once a day, for 15 days before pulp exposure and, subsequently, 30 days after pulp exposure. Rats were killed 30 days after pulp exposure, and jaws were subjected to histologic and immunohistochemical analyses. Immunohistochemical analyses were performed to detect tartrate-resistant acid phosphatase-positive osteoclasts and osteocalcinpositive osteoblasts on the bone surface of periapical area. Results were statistically evaluated by using analysis of variance and Tukey honestly significant difference, and P < .05 was considered statistically significant. Results: The bone resorption lesion was significantly larger in the AP group compared with AP-O, C, and C-O groups (P < .05). The level of inflammatory cell infiltration was significantly elevated, and the number of tartrate-resistant acid phosphatase-positive osteoclasts was significantly higher in the periapical lesions of the AP group compared with AP-O, C, and C-O groups (P < .05). The number of osteocalcin-positive osteoblasts was significantly increased in the AP-O group compared with the AP group (P > .05). Conclusions: Supplementation with u-3 PUFAs not only suppresses bone resorption but also promotes new bone formation in the periapical area of rats with AP in conjunction with downregulation of inflammatory cell infiltration into the lesion. (J Endod 2017;43:970-976) 
resorption processes in either human patients with apical periodontitis or animal models of endodontic infection.
Osteocalcin (OCN) plays a key role as a calcium-binding protein and is one of the most abundant non-collagenous proteins in bone tissue (16) . The expression of OCN is considered to be a biomarker of bone formation (17) . Especially, OCN is produced by osteoblast cells in their late stage of differentiation (18) . Although it has been reported that u-3 PUFAs can promote homeostatic osteoblastogenesis-mediated new bone formation (19) , the effects of u-3 PUFAs on the expression of OCN, as well as on pathogenic bone remodeling, remain unclear.
Therefore, this study aimed to evaluate the effect of the dietary supplement u-3 PUFAs on the pathogenic bone resorption induced in a rat model of apical periodontitis by pulp exposure-elicited endodontic infection. To evaluate the impact of u-3 PUFAs on dysregulated bone remodeling processes, tartrateresistant acid phosphatase (TRAP)-positive osteoclast cells, as well as OCN-positive osteoblasts, were monitored through histologic and immunohistochemical analyses.
Materials and Methods

Experimental Animals
The experimental protocol was approved by the Institutional Ethics Committee (CEUA 2014-00550) of UNESP-Universidade Estadual Paulista, Sao Paulo, Brazil and conducted in accordance with relevant guidelines. Twenty-eight 6-week-old male Wistar rats (Rattus norvegicus albinus) weighing 200-250 g each were used in this study. The rats were housed in a mini-isolator (Alesco, São Paulo, SP, Brazil) in temperature-controlled rooms and given ad libitum access to water and food.
The rats were randomly assigned into 4 groups (7 rats/group):
1. Control untreated rats (C) 2. Healthy rats treated with u-3 PUFAs (C-O) 3. Rats with pulp exposure-induced AP 4. Rats with pulp exposure-induced AP treated with u-3 PUFAs (AP-O)
Supplementation with u-3 PUFAs Rats in the C-O and AP-O groups were orally gavaged with u-3 PUFAs (Omega 3 Catarinense-Laborat orio Catarinense S.A, Joinville, SC, Brazil) (water solution, 40 mg/kg; 60% EPA and 40% DHA, once a day), whereas rats in groups C and AP received control distilled water during 15 days before AP induction (prophylactic administration) and 30 days after AP induction (therapeutic administration). As a consequence, rats were treated with either u-3 PUFAs or control water for a total period of 45 days (12, 13) .
Induction of AP
Rats were anesthetized with ketamine (87 mg/kg; Francotar; Virbac do Brazil Ind. e Com. Ltda., Roseira, SP, Brazil) and xylazine (13 mg/kg; Rompun; Bayer S. A., São Paulo, SP, Brazil). The pulp of the right mandibular first molar was exposed by using a dental round bur (Broca Ln Long Neck; Maillefer, Dentisply Ind e Com Ltda, Petr opolis, SP, Brazil) (groups AP and AP-O) for the development of AP. The coronal pulp tissue was exposed to the oral cavity for 30 days.
Immunohistologic Analyses
Mandibles sampled from killed rats were decalcified in 10% EDTA for 30 days and submitted to conventional histologic processing for the creation of paraffin-embedded tissue sections. Semi-serial sections (4 mm) were performed in the laterolateral direction, allowing sectioning of the mandibular first molar in its longitudinal axis. Sections were stained with hematoxylin-eosin (H&E) or submitted to immunohistochemistry by using an indirect immunoperoxidase technique for TRAP (primary antibody goat anti-TRAP SC 30832; Santa Cruz Biotechnology, Santa Cruz, CA) and primary antibody rabbit anti-OCN SC-30044 for OCN, following the previously described protocol (20) . Histopathologic, histometric, and immunohistochemical analyses were performed by a certified histologist (E.E.) who was blinded to the experimental groups.
Histologic analysis was conducted by using the following parameters: nature and extension of inflammation, presence and extension of necrosis, state of vasculature, and pattern of cellularity of dental and periapical tissues.
The intensity of inflammatory infiltration was graded as follows: absent (0 to few inflammatory cells: score 1), mild (<25 inflammatory cells: score 2), moderate (25-125 inflammatory cells: score 3), or severe (>125 inflammatory cells: score 4).
For AP and AP-O groups, the area of periapical lesion associated with the distal root of the mandibular first molars was histometrically measured. The area was calculated by rounding up the lesion boundary, considering the outer external surface of alveolar bone, and it was expressed in square micrometers. For each rat, 7 serial histologic sections were measured histometrically by using an image processing system that consisted of a light microscope (DM 4000 B; Leica), a color camera (DFC 500; Leica, Wetzlar, Germany), a color image processor (Leica Qwin V3 software; Leica), and a personal computer (Intel Core I5, Intel Corp, Santa Clara, CA; Windows 10, Microsoft Corp, Redmond, WA). The AP areas were determined for each side, and the average value (mean AE standard deviation) was calculated for each experimental group.
The numbers of osteoclasts and osteoblasts were analyzed in the histologic section used for histometric analysis. 
Statistical Analysis
The numbers of TRAP-positive cells, OCN-positive cells, and lesion size were statistically determined by using analysis of variance for multiple comparisons, and the Tukey test was used for pairwise comparisons at 5% significance. Histologic findings were analyzed with the Kruskal-Wallis test. The Dunn method was used for pairwise comparisons at 5% significance. Statistical analyses were performed by using SigmaPlot software (San Jose, CA).
Results
Histopathologic and Histometric Analysis
To evaluate the effects of u-3 PUFAs on cell infiltrate in the AP, histologic images of H&E-stained periapical area in the different experimental groups of rats killed at day 30 were performed and are shown in Figure 1 . No sign of inflammation was noted in the periapical tissue of C or C-O groups (Fig. 1A and B, E and F). However, in the AP and AP-O groups, the dental pulp showed signs of total necrosis at 30 days after pulp exposure, and the enlargement of periapical space between bone and cementum of tooth apex was observed, indicating that bone surrounding apex was pathogenically resorbed in response to pulp exposure ( Fig. 1C and D, G and H) . Furthermore, these lesions were primarily composed of inflammatory infiltrates, including neutrophils and mononuclear cells. Statistical analysis showed that the magnitude of bone loss was higher in the AP group compared with the AP-O, C-O, and C groups (P < .05). The intensity of inflammatory infiltration was greater in the AP group (Fig. 1C and D) compared with C ( Fig. 1A and B), C-O (Fig. 1E and F) , and AP-O groups ( Fig. 1G and H) (P < .05) ( Table 1) .
To evaluate the effects of u-3 PUFAs in the bone resorption, the area of AP was measured histometrically. The area of periapical lesion of mandibular first molar was larger in the AP-O (Fig. 1G and H) and AP ( Fig. 1C and D) groups when compared with the C (Fig. 1A and B) and C-O groups (Fig. 1E and F) (P < .05). In addition, AP was more evident in the AP group when compared with the AP-O group (P < .05) (Fig. 1C  and D, G and H, Table 1 ).
Histologic Evaluation of TRAP-positive Osteoclasts and OCN-positive Cells That Emerged in Periapical Lesion
To evaluate bone remodeling and effect of w-3 PUFAs on osteoclastogenesis, we performed TRAP staining.
The histochemistry images of TRAP staining are shown in Figure 2 . The number of TRAP-positive multinucleated cells per millimeter on the alveolar bone surface of rats induced of AP was higher in the AP (Fig. 2E , F, and I) and AP-O (Fig. 2G-I ) groups compared with the C (Fig. 2A, B, and I) or C-O groups (Fig. 2C, D , and I) (P < .05). In addition, the AP group showed a higher number of TRAP-positive cells when compared with the AP-O group (P < .05) (Fig. 2E-I) .
To evaluate bone remodeling and effect of u-3 PUFAs on osteoblastogenesis, we performed histochemistry to detect OCN-positive cells. The histochemistry images of OCN-positive cells are shown in Figure 1 . Histologic images of periapical lesions at 30 days after pulp exposure (H&E staining). (A and B) Group C. Periapical region is free of inflammatory infiltrates (original magnification, Â100 and Â200, respectively). (E and F) Group C-O. Similar to C, the periapical region is free of inflammatory infiltrates (original magnification, Â100 and Â200, respectively). (C and D) Group AP. Intense infiltration of inflammatory cells in the area surrounding tooth apex can be observed. Severe disorganization of periodontal ligament and large bone resorption area are visible (hematoxylin; original magnification, Â100 and Â200, respectively). (G and H) Group AP-O. Compared with AP, a decreased level of inflammatory infiltrates is observed in periodontal ligament region. Size of bone resorption is also diminished compared with AP group (hematoxylin; original magnification, Â100 and Â200, respectively). Arrowheads indicate margins of apical periodontitis. dp, dental pulp; pdl, periodontal ligament; ce, cementum; oa, alveolar bone. *Site of infiltration of inflammatory cells. AP, rats with pulp exposure-induced AP; AP-O, rats with pulp exposure-induced AP treated with u-3 PUFAs; C, control untreated rats; C-O, healthy rats treated with u-3 PUFAs. *Different superscript letters indicate significant statistical differences in rows (P < .05). Basic Research-Biology (Fig. 3A, B , and I) and C-O (Fig. 3C, D, and I) groups compared with the AP (Fig. 3E, F, and I) or AP-O groups (Fig. 3G-I ) (P < .05). In addition, the AP-O group showed a higher number of OCN-positive cells when compared with the AP group (P < .05) (Fig. 3E-I) .
Discussion
In the present study, systemic administration of u-3 PUFAs not only inhibited osteoclastogenesis but also promoted osteoblastogenesis in the context of bone resorption lesion of apical periodontitis, suggesting that u-3 PUFAs can act on 2 different bone cells and ameliorate the pathogenic bone loss outcomes of this disease. The pathogenic bone resorption induced in the AP group by pulp exposure was significantly suppressed by systemic administration with u-3 PUFAs in the AP-O group. This result agrees with previous studies performed in the rat model of periodontitis and human patients with periodontitis (14, 21, 22) . However, other studies concluded that dietary supplement with u-3 PUFAs had no effect on bone resorption in human patients with periodontitis (12, 13, 23) . Nonetheless, none of these studies has ever addressed the effects of u-3 PUFAs on pathogenic bone outcomes of apical periodontitis.
Rats that received prophylactic administration of u-3 PUFAs in addition to therapeutic administration showed better outcomes in suppressing the bone resorption induced in AP compared with rats that received therapeutic administration alone (12, 13) . To explain, prophylactic administration of u-3 PUFAs for 2 weeks allowed the accumulation of EPA and DHA in the cell membrane (24) , eventually promoting the robustness of membrane stability and fluidity in response to inflammatory challenge by the induction of periodontitis. It would be intriguing to examine in a future study whether prophylactic administration of u-3 PUFAs can also increase the efficacy of u-3 PUFAs on pathogenic bone loss induced by pulp exposure.
The present study corroborates the findings (25) in which rats induced of endodontic infection were supplemented with fish oil. Compared with experimental rats that received placebo treatment, a decreased number of osteoclasts was seen in periapical lesions of rats that received u-3 PUFAs. Some in vitro studies have also demonstrated that u-3 PUFAs could decrease osteoclastogenesis (26) (27) (28) (29) . It is well-established that the metabolites of polyunsaturated fatty acids, eg, prostaglandin, hydroxyeicosatetraenoic acids, and leukotrienes, act on osteoclast progenitors and suppress their receptor activator of nuclear factor kappa B ligand-mediated differentiation and activation (30, 31) . According to an in vitro study, the effects of DHA on osteoclastogenesis are, at least in part, mediated by lipoxygenase, a metabolic derivative of DHA (32) .
The level of OCN is considered a marker of new bone formation (19) . Thus, our results showing an elevated number of OCN-positive osteoblasts in the u-3 PUFAs-treated AP rats suggested that u-3 PUFAs could also improve new bone formation, even in the context of inflammatory bone resorption lesion. Further studies to elucidate the molecular mechanisms of bone formation should be performed to verify this hypothesis.
In addition, we found a greater number of inflammatory infiltrates in the periapical area of the AP group, causing more severe inflammatory infiltration, when compared with AP-O and C groups. Inflammation is characterized by a complex sequence of events involving alterations in the inflammatory network, as well as rearrangement of innate immune cell populations and changes in their activation status (33) . Therefore, the presence of inflammatory cells in the AP and AP-O groups indicates inflammatory reaction to bacterial challenge in the periapical area. Reduced inflammatory status in the AP-O group supports some studies showing the effects of u-3 PUFAs during inflammation (34, 35) . These studies suggested that u-3 PUFAs can competitively inhibit the production of arachidonic acid metabolites via the cyclooxygenase and lipoxygenase pathways, thus reducing proinflammatory arachidonic mediators (34) and decreasing inflammatory response (35) .
The findings herein presented indicate that systemic supplementation with u-3 PUFAs can decrease bone resorption in the periapical area of rats with apical periodontitis, as well as the number of infiltrating inflammatory cells and the number of osteoclasts. Furthermore, u-3 PUFAs promoted osteoblastogenesis in the lesion. In summary, this study lays the groundwork for further investigation of u-3 PUFAs as a therapeutic regimen for apical periodontitis.
